BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21493)

  • 1. [Ways of controlling reactions subserved by non-syngenous immunocompetent cells].
    Kaulen DR; Maianskiĭ DN
    Usp Sovrem Biol; 1977; 84(1):38-52. PubMed ID: 21493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Participation of phytohemagglutinin-transformed mouse lymphocytes in development of the "graft-versus-host" reaction].
    Nesterenko VG; Koval'chuk LV
    Biull Eksp Biol Med; 1976 Sep; 82(9):1096-8. PubMed ID: 11013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
    Norin AJ; Emeson EE
    J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes in immunobiology.
    Gotoff SP
    Adv Pediatr; 1970; 17():139-83. PubMed ID: 4394438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ways of controlling reactions attributable to non-syngenous immunocompetent cells].
    Kaulen DR; Maianskiĭ DN
    Usp Sovrem Biol; 1977; 84(4):38-52. PubMed ID: 27024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of prodigiosin and its combination with immunodepressants on the graft versus host reaction in mice].
    Alekhin EK; Shigaev NI
    Antibiotiki; 1983 Nov; 28(11):842-5. PubMed ID: 6651274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 8. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of antibodies against the antigen-recognizing receptors of T-lymphocytes in a syngenous system].
    Nesterenko VG; Cherniakhovskaia IIu
    Biull Eksp Biol Med; 1977 Dec; 84(12):693-5. PubMed ID: 304363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J; Kaden K
    Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Change in mouse peripheral blood during specific and combined suppression of transplantation immunity].
    Shatalova IN; Nastoiashchaia NN; Artsimovich NG; Sergel' OS
    Dokl Akad Nauk SSSR; 1973; 210(6):1450-2. PubMed ID: 4578780
    [No Abstract]   [Full Text] [Related]  

  • 14. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 15. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in graft--ersus-host reactivity and peripheral leukocytes in mice after erythropoietin treatment.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1975 Aug; 3(4):234-43. PubMed ID: 240732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.